Search by Drug Name or NDC
NDC 43066-0015-10 ROPIVACAINE HYDROCHLORIDE 2 mg/mL Details
ROPIVACAINE HYDROCHLORIDE 2 mg/mL
ROPIVACAINE HYDROCHLORIDE is a EPIDURAL; INFILTRATION; PERINEURAL INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is ROPIVACAINE HYDROCHLORIDE.
Product Information
| NDC | 43066-0015 |
|---|---|
| Product ID | 43066-015_4157bbc3-8a96-4b79-890d-50ff00bdf4c9 |
| Associated GPIs | 69100070102008 |
| GCN Sequence Number | 028217 |
| GCN Sequence Number Description | ropivacaine HCl/PF VIAL 2 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 46081 |
| HICL Sequence Number | 036674 |
| HICL Sequence Number Description | ROPIVACAINE HCL/PF |
| Brand/Generic | Generic |
| Proprietary Name | ROPIVACAINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ropivacaine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | EPIDURAL; INFILTRATION; PERINEURAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | ROPIVACAINE HYDROCHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212808 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43066-0015-10 (43066001510)
| NDC Package Code | 43066-015-10 |
|---|---|
| Billing NDC | 43066001510 |
| Package | 10 VIAL in 1 CARTON (43066-015-10) / 20 mL in 1 VIAL (43066-015-01) |
| Marketing Start Date | 2020-04-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |